Status:

UNKNOWN

Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis

Lead Sponsor:

Federico II University

Conditions:

Atopic Dermatitis

Eligibility:

All Genders

6-36 years

Phase:

NA

Brief Summary

Atopic dermatitis (AD) is a multifactorial, chronic inflammatory skin disorder that results in areas of dry, itchy skin. AD affects up to 20% of children in Western societies and represents a prevalen...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Children aged 6-36 months
  • diagnosis of Atopic Dermatitis according to SCORAD index
  • Exclusion Criteria
  • Age \< 6 months
  • age \> 36 months,
  • skin infections,
  • ichthyosis,
  • food allergies,
  • other allergic diseases,
  • chronic systemic diseases,
  • congenital cardiac defects,
  • active tuberculosis,
  • autoimmune diseases,
  • immunodeficiency,
  • chronic inflammatory bowel diseases,
  • celiac disease,
  • cystic fibrosis,
  • metabolic diseases,
  • malignancy,
  • chronic pulmonary diseases,
  • malformations of the gastrointestinal and/or respiratory tract,
  • administration of prebiotics/ probiotics/symbiotic/systemic immunomodulators during the 4 weeks before enrolment,
  • treatments with topical immunomodulators (Tacrolimus or Pimecrolimus) over the three months prior to enrolment;
  • use of corticosteroids or calcineurin antagonists or phototherapy in the previous 4 weeks,
  • use of systemic antibiotics or anti-mycotic drugs during 4 weeks before study entry;
  • investigator's uncertainty about the willingness or ability of the subject to comply with the protocol requirements;
  • participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study;
  • hypersensitivity to components contained in study product.

Exclusion

    Key Trial Info

    Start Date :

    May 15 2019

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2020

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT03863418

    Start Date

    May 15 2019

    End Date

    December 31 2020

    Last Update

    March 6 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University of Naples Federico II

    Naples, Italy, 80131

    Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic Dermatitis | DecenTrialz